| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.06B | 113.84B | 105.83B | 102.26B | 101.01B | 92.17B |
| Gross Profit | 15.58B | 17.67B | 14.35B | 15.05B | 17.79B | 18.64B |
| EBITDA | 6.07B | 9.43B | 4.00B | 7.32B | 10.04B | 12.62B |
| Net Income | -1.21B | 5.66B | -2.44B | -712.00M | 1.64B | 5.90B |
Balance Sheet | ||||||
| Total Assets | 131.18B | 144.65B | 136.50B | 144.67B | 138.09B | 135.04B |
| Cash, Cash Equivalents and Short-Term Investments | 22.08B | 26.92B | 20.40B | 26.34B | 25.15B | 29.61B |
| Total Debt | 38.02B | 44.35B | 40.28B | 38.90B | 37.53B | 39.88B |
| Total Liabilities | 65.31B | 72.09B | 70.35B | 73.75B | 75.55B | 77.81B |
| Stockholders Equity | 65.87B | 72.56B | 66.14B | 70.92B | 62.54B | 57.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 958.00M | -6.80B | -2.24B | -2.18B | -796.00M |
| Operating Cash Flow | 0.00 | 6.32B | -2.18B | 2.21B | 2.74B | 8.29B |
| Investing Cash Flow | 0.00 | -2.12B | -4.53B | -1.78B | -4.09B | -7.91B |
| Financing Cash Flow | 0.00 | 1.90B | -186.00M | -252.00M | -3.55B | 1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥15.78T | 66.70 | 8.95% | 1.88% | 5.02% | 2.02% | |
68 Neutral | ¥46.38B | 12.41 | ― | 4.53% | 5.02% | 354.47% | |
64 Neutral | ¥6.65T | 34.00 | ― | 1.41% | 13.61% | 17.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥31.28B | 4.20 | ― | 1.95% | 7.56% | ― | |
61 Neutral | ¥264.01B | 41.45 | ― | 2.18% | -3.43% | 9.82% | |
51 Neutral | ¥116.72B | 40.51 | 2.26% | ― | 11.52% | 5786.05% |